Australia markets closed

Mersana Therapeutics, Inc. (MRSN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.3300-0.0700 (-2.92%)
At close: 04:00PM EDT
2.3300 0.00 (0.00%)
After hours: 06:12PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-134,813
-171,670
-204,212
-170,060
-88,045
Depreciation & amortisation
1,621
1,517
927
855
1,010
Stock-based compensation
19,389
21,136
21,522
18,409
7,172
Change in working capital
-57,917
-18,763
130,322
10,085
5,105
Accounts receivable
0
30,000
-30,000
0
0
Accounts payable
-14,974
-6,080
947
483
942
Other working capital
-173,923
-171,050
-51,560
-140,636
-75,169
Other non-cash items
3,461
3,467
3,540
723
148
Net cash provided by operating activities
-172,534
-168,882
-49,363
-139,988
-74,696
Cash flows from investing activities
Investments in property, plant and equipment
-1,389
-2,168
-2,197
-648
-473
Purchases of investments
-179,641
-155,919
-247,519
0
0
Sales/maturities of investments
226,970
277,970
97,000
0
37,500
Net cash used for investing activities
45,940
119,883
-152,716
-648
37,027
Cash flows from financing activities
Debt repayment
-412
-412
-272
-5,701
-313
Common stock issued
77,655
93,539
150,893
43,087
227,026
Other financing activities
-
-
-
-259
-
Net cash used provided by (used for) financing activities
78,955
94,675
153,017
63,646
230,412
Net change in cash
-47,639
45,676
-49,062
-76,990
192,743
Cash at beginning of period
123,303
129,363
178,425
255,415
62,672
Cash at end of period
75,664
175,039
129,363
178,425
255,415
Free cash flow
Operating cash flow
-172,534
-168,882
-49,363
-139,988
-74,696
Capital expenditure
-1,389
-2,168
-2,197
-648
-473
Free cash flow
-173,923
-171,050
-51,560
-140,636
-75,169